$1.48 -0.14 (-8.95%)
2/13/2012 10:07 AM

K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Featured Broker Partners


Advertisement